← Evidence map

ArticleAntimicrobial agents and chemotherapy2005

Maraviroc (UK-427,857), a potent, orally bioavailable, and selective small-molecule inhibitor of chemokine receptor CCR5 with broad-spectrum anti-human immunodeficiency virus type 1 activity.

Patrick Dorr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

529 papers cite itlatest 60 shown

2005
…
2018
2019
2020
2022
2023
2024
2025
2026
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 16251317